Singapore-based private equity firm in Indonesia pharma deal
SINGAPORE-BASED private equity firm Quadria Capital has sealed a "multi-million dollar" deal with its investment in Indonesia's PT Soho Global Health (SGH), in a partnership with German development finance institution DEG.
"The funds will be used to create access to innovative, differentiated drugs through in-licensing from developed markets, acquire strategic assets and support the growth of the medical device sector," Quadria Capital said in a statement on Thursday.
Quadria Capital, which focuses on the healthcare sector, also said that this transaction is the first private equity deal in Indonesia's pharmaceutical industry.
SGH produces, markets and distributes natural medicines, prescription and over-the-counter products across Indonesia. Its distribution network covers more than 80 per cent of hospitals and 90 per cent of pharmacies in Indonesia.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Banking & Finance
Basel Committee adds climate risks to banking supervision standards
Crypto firm sues SEC to fend off oversight of Ethereum
Great Eastern chairman appeals for patience as shareholders fume over share price ‘disaster’
S&P Global first-quarter profit beats estimates on strong product demand
Thai banks cut rate for some borrowers after push from PM
Money laundering accused who faces 22 charges to plead guilty on May 14